New eye drop study targets stubborn dry eye inflammation
NCT ID NCT07463950
Summary
This study is observing how well an already-approved eye drop (Vevizye®) works for people with moderate to severe dry eye disease who still have inflammation and symptoms after using artificial tears. It will measure changes in eye dryness, redness, and other signs over 12 weeks. The goal is to better understand how this anti-inflammatory treatment helps control the condition in real-world use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Clinical Pharmacology, Medical University of Vienna, Austria
RECRUITINGVienna, Vienna, 1090, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.